首页> 外文期刊>Therapeutics and Clinical Risk Management >Boussignac CPAP system for brain death confirmation with apneic test in case of acute lung injury/adult respiratory distress syndrome?–?series of cases
【24h】

Boussignac CPAP system for brain death confirmation with apneic test in case of acute lung injury/adult respiratory distress syndrome?–?series of cases

机译:Boussignac CPAP系统可在急性肺损伤/成人呼吸窘迫综合征的情况下通过呼吸暂停测试确认脑死亡-系列病例

获取原文
获取外文期刊封面目录资料

摘要

Introduction: There are some patients with severe respiratory disturbances like adult respiratory distress syndrome (ARDS) and suspicion of brain death, for whom typical performance of the apneic test is difficult to complete because of quick desaturation and rapid deterioration without effective ventilation. To avoid failure of brain death confirmation and possible loss of organ donation another approach to apneic test is needed. We present two cases of patients with clinical symptoms of brain death, with lung pathology (acute lung injury, ARDS, lung embolism and lung infection), in whom apneic tests for recognizing brain death were difficult to perform. During typical performance of apneic test involving the use of oxygen catheter for apneic oxygenation we observed severe desaturation with growing hypotension and hemodynamic destabilization. But with the use of Boussignac CPAP system all necessary tests were successfully completed, confirming the patient’s brain death, which gave us the opportunity to perform procedures for organ donation. The main reason of apneic test difficulties was severe gas exchange disturbances secondary to ARDS. Thus lack of positive end expiratory pressure during classical performance of apneic test leads to quick desaturation and rapid hemodynamic deterioration, limiting the observation period below dedicated at least 10-minute interval. Conclusion: The Boussignac CPAP system may be an effective tool for performing transparent apneic test in case of serious respiratory disturbances, especially in the form of acute lung injury or ARDS.
机译:简介:有些患者患有严重的呼吸系统疾病,例如成人呼吸窘迫综合征(ARDS)和怀疑脑死亡,由于快速的去饱和和快速恶化而没有有效的通气,他们难以完成典型的呼吸暂停测试。为了避免脑死亡确认失败和可能的器官捐献丢失,需要另一种进行呼吸暂停测试的方法。我们提出了两例具有脑死亡临床症状,肺部病理(急性肺损伤,ARDS,肺栓塞和肺部感染)的患者,其中难以进行用于识别脑死亡的呼吸暂停测试。在典型的涉及使用氧气导管进行呼吸道充氧的呼吸道测试中,我们观察到严重的饱和度降低,血压升高,血流动力学不稳定。但是通过使用Boussignac CPAP系统,所有必要的测试均成功完成,确认了患者的脑死亡,这为我们提供了进行器官捐赠程序的机会。呼吸暂停测试困难的主要原因是继ARDS之后严重的气体交换紊乱。因此,在进行典型的呼吸暂停测试过程中,呼气末正压的缺乏会导致快速去饱和和快速的血液动力学恶化,从而将观察期限制在专用的至少10分钟间隔以下。结论:Boussignac CPAP系统可能是在发生严重呼吸异常(尤其是急性肺损伤或ARDS形式)的情况下进行透明呼吸暂停测试的有效工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号